Tinos Therapeutics, Inc.

CIK 2088485 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tinos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 17, 2026D/A0002088485-26-000001
Sep 26, 2025D0002088485-25-000001